AMGEN Inc [AMGN] stock is trading at $290.92, up 0.82%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AMGN shares have gain 4.69% over the last week, with a monthly amount drifted -6.62%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On November 15, 2024, Wolfe Research initiated with a Peer Perform rating. Citigroup started tracking the stock assigning a Neutral rating and suggested a price target of $335 on November 14, 2024. Bernstein initiated its recommendation with a Outperform and recommended $380 as its price target on October 17, 2024. Truist downgraded its rating to Hold for this stock on October 14, 2024, and upped its price target to $333. In a note dated September 27, 2024, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $405 on this stock.
AMGEN Inc [AMGN] stock has fluctuated between $253.30 and $346.85 over the past year. Currently, Wall Street analysts expect the stock to reach $326.33 within the next 12 months. AMGEN Inc [NASDAQ: AMGN] shares were valued at $290.92 at the most recent close of the market. An investor can expect a potential return of 12.17% based on the average AMGN price forecast.
Analyzing the AMGN fundamentals
AMGEN Inc [NASDAQ:AMGN] reported sales of 33.23B for the trailing twelve months, which represents a growth of 11.16%. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.67 and Total Capital is 0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 10.23.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 287.34 points at the first support level, and at 283.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 293.25, and for the 2nd resistance point, it is at 295.58.
Ratios To Look Out For
For context, AMGEN Inc’s Current Ratio is 1.26. Further, the Quick Ratio stands at 0.95, while the Cash Ratio is 0.52. Considering the valuation of this stock, the price to sales ratio is 4.71, the price to book ratio is 26.58 and price to earnings (TTM) ratio is 38.55.
Transactions by insiders
Recent insider trading involved Santos Esteban, EVP, Operations, that happened on Feb 19 ’25 when 8711.0 shares were sold. EVP & Chief Technology Officer, REESE DAVID M completed a deal on Feb 21 ’25 to sell 25225.0 shares. Meanwhile, EVP & Chief Technology Officer REESE DAVID M sold 8711.0 shares on Feb 19 ’25.
